MARATTO

article · BMJ Open

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial

2026Open accessUniversité de Yaoundé I

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

NCT06203132; EU-CT, 2023-508626-10-00.

Research topics

  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1136/bmjopen-2025-110560

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.